UPLOAD Filing
Silexion Therapeutics Corp
Date: Aug. 28, 2025 · CIK: 0002022416 · Accession: 0000000000-25-009294
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289860
Letter
August 28, 2025 Ilan Hadar Chairman and Chief Executive Officer Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan, Israel 5250606 Re:Silexion Therapeutics Corp Registration Statement on Form S-1 Filed August 26, 2025 File No. 333-289860 Dear Ilan Hadar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jonathan M. Nathan, Esq.
Show Raw Text
August 28, 2025
Ilan Hadar
Chairman and Chief Executive Officer
Silexion Therapeutics Corp
12 Abba Hillel Road
Ramat Gan, Israel 5250606
Re:Silexion Therapeutics Corp
Registration Statement on Form S-1
Filed August 26, 2025
File No. 333-289860
Dear Ilan Hadar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jonathan M. Nathan, Esq.